<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00908427</url>
  </required_header>
  <id_info>
    <org_study_id>2004-05-09</org_study_id>
    <nct_id>NCT00908427</nct_id>
  </id_info>
  <brief_title>Impact of 80 W KTP Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia</brief_title>
  <official_title>Impact of 80 Watt KTP Photoselective Laser Vaporization Prostatectomy on Severity of Obstruction in Benign Prostatic Hyperplasia: 6-Month Results of a Nonrandomized Prospective Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compared the efficacy of 80W KTP photoselective laser
      vaporization prostatectomy (PVP) and transurethral resection of the prostate (TURP) in
      reducing the volume of prostate and relieving the obstruction in men with benign prostatic
      hyperplasia (BPH) on non-randomized controlled design.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">May 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The changes of bladder outlet obstruction index (BOOI)</measure>
    <time_frame>6months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The changes of Quality of Life (QoL) parameters</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of Uroflowmetry (UFM) and Postvoid residual urine(PVR)</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of detrusor pressure at maximum flow rate (PdetQmax)parameters</measure>
    <time_frame>6months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of International Prostatic Symptom Scores (IPSS)</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of Schafer obstruction grade parameters</measure>
    <time_frame>6months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of prostate volume</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative catheterization days</measure>
    <time_frame>immediate postoperative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>During all study periods</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The changes of the hemoglobin and the serum sodium and the serum PSA</measure>
    <time_frame>immediate postoperative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of IIEF score</measure>
    <time_frame>6, 12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <condition>Benign Prostatic Hyperplasia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PVP group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TURP group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>photoselective vaporization prostatectomy (PVP)</intervention_name>
    <description>PVP using 80 W KTP laser with a Greenlight system (GreenLight PVTM, LaserscopeÂ®, San Jose, CA)</description>
    <arm_group_label>1</arm_group_label>
    <other_name>PVP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transurethral resection of the prostate</intervention_name>
    <description>Standard transurethral resection of the prostate using electrocautery loop</description>
    <arm_group_label>2</arm_group_label>
    <other_name>TURP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Symptomatic BPH

          -  International Score Prostate Symptom (IPSS) of 13 or greater

          -  prostate volume of 30 to 100 ML

          -  Peak urinary flow rate (Qmax) less than 15 mL/s with a voided volume of &gt;125 mL and a
             PVR &lt;350mL

          -  Able to give fully informed consent

        Exclusion Criteria:

          -  Subjects with histological diagnosis of prostate cancer

          -  Subjects with history of chronic urinary retention

          -  Subjects with urethral stricture,

          -  Subjects with bladder neck contracture

          -  Subjects with urinary tract infection

          -  Subjects with prostate volume on TRUS of &gt;100 mL

          -  Subjects with suspected neurogenic bladder dysfunction

          -  Subjects who, in the opinion of investigator, are not likely to complete the study for
             whatever reason
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sung-Won Lee, Ph.D.,M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2009</study_first_submitted>
  <study_first_submitted_qc>May 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2009</study_first_posted>
  <last_update_submitted>May 22, 2009</last_update_submitted>
  <last_update_submitted_qc>May 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Sung Won Lee/Professor</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>benign prostatic hyperplasia</keyword>
  <keyword>KTP laser</keyword>
  <keyword>transurethral resection of prostate</keyword>
  <keyword>urinary bladder neck obstruction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperplasia</mesh_term>
    <mesh_term>Prostatic Hyperplasia</mesh_term>
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

